Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 536.45 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Vertex Pharmaceuticals Incorporated (VRTX) had Earnings per Share (EPS) (Diluted) of $2.56 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.44B
$653.60M
$526.10M
$2.91B
$2.73B
$712.90M
$70.50M
$783.40M
$783.40M
$653.60M
$653.60M
$653.60M
$653.60M
$712.90M
$782.10M
253.50M
255.20M
$2.58
Earnings per Share (EPS) (Diluted)
$2.56
Balance Sheet Financials
$11.69B
$1.71B
$21.05B
$32.74B
$5.00B
$3.50B
$6.83B
$11.83B
$20.91B
$9.97B
$20.91B
253.52M
Cash Flow Statement Financials
$3.20B
$-6.58B
$3.33B
$5.09B
$4.99B
$-99.20M
$511.00M
--
--
Fundamental Metrics & Ratios
2.34
--
--
0.14
0.22
84.71%
20.72%
20.72%
--
22.77%
19.00%
$2.85B
--
--
--
0.11
0.23
1.49
60.45
3.13%
6.56%
2.00%
2.68%
$82.47
$11.18
$12.53